摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzyl 4-(2-bromo-10-oxo-9,10-dihydro-4H-benzo[b]furo[3,2-e]azepin-6-yl)piperazine-1-carboxylate | 1357089-55-4

中文名称
——
中文别名
——
英文名称
benzyl 4-(2-bromo-10-oxo-9,10-dihydro-4H-benzo[b]furo[3,2-e]azepin-6-yl)piperazine-1-carboxylate
英文别名
——
benzyl 4-(2-bromo-10-oxo-9,10-dihydro-4H-benzo[b]furo[3,2-e]azepin-6-yl)piperazine-1-carboxylate化学式
CAS
1357089-55-4
化学式
C24H22BrN3O4
mdl
——
分子量
496.36
InChiKey
MLCRYPRTWYLQSU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    609.1±55.0 °C(predicted)
  • 密度:
    1.473±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.66
  • 重原子数:
    32.0
  • 可旋转键数:
    3.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    75.02
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    benzyl 4-(2-bromo-10-oxo-9,10-dihydro-4H-benzo[b]furo[3,2-e]azepin-6-yl)piperazine-1-carboxylatepotassium phosphate 、 1,1'-bis(diphenylphosphino)ferrocene-palladium(II)dichloride dichloromethane complex 作用下, 以 1,4-二氧六环 为溶剂, 反应 6.0h, 以89%的产率得到benzyl 4-(2-(4-fluorophenyl)-10-oxo-9,10-dihydro-4H-benzo[b]furo[3,2-e]azepin-6-yl)piperazine-1-carboxylate
    参考文献:
    名称:
    Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors
    摘要:
    Facile synthesis of two new series of tetracyclic azepine and oxazocine analogs is described. These analogs were evaluated for their potential as MAPKAP-K2 (MK2) inhibitors and several were found to be potent at inhibiting MK2 with a non-ATP competitive binding mode. Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2011.11.113
  • 作为产物:
    参考文献:
    名称:
    Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors
    摘要:
    Facile synthesis of two new series of tetracyclic azepine and oxazocine analogs is described. These analogs were evaluated for their potential as MAPKAP-K2 (MK2) inhibitors and several were found to be potent at inhibiting MK2 with a non-ATP competitive binding mode. Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2011.11.113
点击查看最新优质反应信息